ME - Nasdaq Biotechnology rejig: VTRS NVCR among added KALA VYNE among deleted
The Nasdaq Biotechnology Index will have a new look on December 20, before the market opens when 129 securities will be added and 21 securities will be deleted as part of the annual reconstitution. Notable additions to the index: Viatris (NASDAQ:VTRS), NovoCure (NASDAQ:NVCR), Anavex Life Sciences (NASDAQ:AVXL), Tonix Pharmaceuticals (NASDAQ:TNXP), Sesen Bio (NASDAQ:SESN), 23andMe Holding (NASDAQ:ME), Curis (NASDAQ:CRIS), CureVac (NASDAQ:CVAC), ADMA Biologics (NASDAQ:ADMA) and Lexicon Pharmaceuticals (NASDAQ:LXRX) Notable deletions to the index: Kala Pharmaceuticals (NASDAQ:KALA), VYNE Therapeutics (NASDAQ:VYNE), Dicerna Pharmaceuticals (NASDAQ:DRNA), Ardelyx (NASDAQ:ARDX), Voyager Therapeutics (NASDAQ:VYGR), Orchard Therapeutics (NASDAQ:ORTX), Calithera Biosciences (NASDAQ:CALA), Unity Biotechnology (NASDAQ:UBX), ANI Pharmaceuticals (NASDAQ:ANIP) and XBiotech (NASDAQ:XBIT). Press Release
For further details see:
Nasdaq Biotechnology rejig: VTRS, NVCR among added, KALA, VYNE among deleted